KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Deferred Taxes (2019 - 2025)

AbbVie (ABBV) has disclosed Deferred Taxes for 7 consecutive years, with -$385.0 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes rose 49.8% to -$385.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$492.0 million through Dec 2025, up 66.05% year-over-year, with the annual reading at -$492.0 million for FY2025, 66.05% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$385.0 million at AbbVie, down from $193.0 million in the prior quarter.
  • The five-year high for Deferred Taxes was $193.0 million in Q3 2025, with the low at -$1.4 billion in Q4 2023.
  • Average Deferred Taxes over 5 years is -$383.0 million, with a median of -$322.5 million recorded in 2023.
  • The sharpest move saw Deferred Taxes plummeted 1726.47% in 2022, then soared 169.68% in 2025.
  • Over 5 years, Deferred Taxes stood at -$745.0 million in 2021, then surged by 30.74% to -$516.0 million in 2022, then plummeted by 169.57% to -$1.4 billion in 2023, then soared by 44.86% to -$767.0 million in 2024, then surged by 49.8% to -$385.0 million in 2025.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$385.0 million, $193.0 million, and -$272.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.